Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1989 1
1990 3
1991 191
1992 483
1993 433
1994 547
1995 458
1996 505
1997 431
1998 582
1999 439
2000 374
2001 412
2002 372
2003 388
2004 411
2005 373
2006 364
2007 312
2008 294
2009 296
2010 324
2011 290
2012 259
2013 291
2014 272
2015 261
2016 248
2017 182
2018 195
2019 114
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

9,623 results
Results by year
Filters applied: . Clear all
Page 1
Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.
Faulds D, et al. Drugs 1993 - Review. PMID 7691501
It may also be of considerable therapeutic benefit in patients with primary biliary cirrhosis, particularly those with less advanced disease. ...To avoid relapse after control of active disease, patients should receive cyclosporin maintenance therapy at the lowest effective dosage. ...
It may also be of considerable therapeutic benefit in patients with primary biliary cirrhosis, particularly those with less advanced …
Ciclosporin and the cat: Current understanding and review of clinical use.
Colombo S and Sartori R. J Feline Med Surg 2018 - Review. PMID 29478396
Although the drug is currently only licensed to treat chronic allergic dermatitis in cats, a small number of reports describe its use in non-dermatological conditions. Evidence base: This article reviews the mechanism of action, pharmacokinetics, drug interactions, adverse effects and clinical use of CsA, both for the licensed indication and for off-label use in the feline patient. ...
Although the drug is currently only licensed to treat chronic allergic dermatitis in cats, a small number of reports describe its use
Consensus on the use of cyclosporine in dermatological practice. Italian Consensus Conference.
Altomare G, et al. G Ital Dermatol Venereol 2014. PMID 25213388
Cyclosporine A (CsA) efficacy and safety have been proven in various dermatoses both in adults and in children even as long-term treatment. ...The paper is mainly focused on the analysis of the optimal therapeutic schemes for psoriasis and atopic dermatitis, in terms of doses and treatment duration, according to individual characteristics and to the severity of the disease. ...
Cyclosporine A (CsA) efficacy and safety have been proven in various dermatoses both in adults and in children even as long-term trea
The use of cyclosporine in dermatology: part II.
Ryan C, et al. J Am Acad Dermatol 2010 - Review. PMID 21093660
Cyclosporine is highly effective in the treatment of a multitude of dermatoses. Concern over its side effect profile has limited its use in dermatology. ...The use of cyclosporine in pregnancy and in the pediatric population is also addressed. LEARNING OBJECTIVES: After completing this learning activity, participants should be familiar with the monitoring guidelines of cyclosporine, its contraindications, its possible drug interactions, its adverse effect profile, and its use in pregnancy and the childhood and adolescent populations....
Cyclosporine is highly effective in the treatment of a multitude of dermatoses. Concern over its side effect profile has limited its
Optimizing the use of cyclosporine in renal transplantation.
Sketris I, et al. Clin Biochem 1995 - Review. PMID 7554239
OBJECTIVE: To review the existing data on the use of cyclosporine (CsA) in kidney transplantation, particularly with respect to therapeutic drug monitoring. DATA SOURCES: A literature search was conducted of applicable articles related to therapeutic drug monitoring of cyclosporine in renal transplantation. ...
OBJECTIVE: To review the existing data on the use of cyclosporine (CsA) in kidney transplantation, particularly with respect t …
[Ciclosporin]
Doutre MS. Ann Dermatol Venereol 2002 - Review. PMID 12055538 French.
Cyclosporine therapeutic and toxic effects may be related to different cyclosporine concentration zones in plasma.
Wu G and Yan SM. Med Hypotheses 2001. PMID 11388789
Different cyclosporine concentration zones can exist in plasma due to the temperature dependency in distribution and association, therefore cyclosporine therapeutic and toxic effects may partially be related to these concentration zones....
Different cyclosporine concentration zones can exist in plasma due to the temperature dependency in distribution and association, the …
Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?
Tesfaye H, et al. Ann Transplant 2008. PMID 19034221 Free article.
BACKGROUND: Cyclosporine, once a corner stone in organ transplantation for decades, its use is expanded to treat several autoimmune conditions despite lacking profound evidence for its advantages. ...CONCLUSIONS: Extended use of cyclosporine in several autoimmune diseases is promising. However, no evidence-based target levels in miscellaneous indications. ...
BACKGROUND: Cyclosporine, once a corner stone in organ transplantation for decades, its use is expanded to treat several autoi …
The use of cyclosporine in dermatology: part I.
Amor KT, et al. J Am Acad Dermatol 2010 - Review. PMID 21093659
In the last decade, many dermatologists have hesitated to use this important drug in their clinical practices because of its toxicity profile. ...LEARNING OBJECTIVES: After completing this learning activity, participants should be able to describe the mechanism of action of cyclosporine, recognize the potential role of cyclosporine in dermatology and the evidence to support this role, and incorporate cyclosporine into his or her prescribing regimens....
In the last decade, many dermatologists have hesitated to use this important drug in their clinical practices because of its toxicity …
9,623 results
Jump to page
Feedback